Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19

OBJECTIVE: To compare the efficacy and outcomes with inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with refractory hypoxemia due to COVID-19. DESIGN: Retrospective Cohort Study. SETTING: Single health system multicenter academic teaching hospitals. PATIENTS OR SUBJECTS: Age...

Descripción completa

Detalles Bibliográficos
Autores principales: Poonam, Pai B. H., Koscik, Rebecca, Nguyen, Trong, Rikhi, Shefali, Lin, Hung-Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236233/
https://www.ncbi.nlm.nih.gov/pubmed/35759496
http://dx.doi.org/10.1371/journal.pone.0270646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236233/
https://www.ncbi.nlm.nih.gov/pubmed/35759496
http://dx.doi.org/10.1371/journal.pone.0270646

Ejemplares similares